GE's cardiac CT platform nets FDA clearance
Article Thumbnail ImageJuly 19, 2012 -- GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new cardiac imaging platform, the Discovery CT750 HD Freedom Edition.
Member Sign In:
  MemberID or E-mail Address:

New Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • The cardiac spectral CT system features Motion Freedom with intelligent motion correction via SnapShot Freeze; Calcium Freedom with enhanced coronary visualization using Gemstone Spectral Imaging (GSI) Cardiac; and Horizon Free for plaque material composition assessment and perfusion calculations.

    GE's SnapShot Freeze technique is designed to reduce coronary motion and to detect vessel motion and velocity. SnapShot Freeze can help determine vessel position and correct the effects of motion during cardiac CT exams.

    The HD Freedom Edition's first U.S. installation was at the University of Washington in Seattle. The CT scanner is installed at two dozen locations in Europe and Japan.

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 All Rights Reserved.